LIMA1 and cancer: Particularly noteworthy, Duethorn et al. observed that EPLIN depletion in pluripotent cells exacerbates blebbing [17], suggesting that in pathological conditions like cancer, this phenomenon may amplify tumor resistance to protease inhibitors.